0

Journal Articles

in Oncology
 121-140 of 480 Articles
Original Investigation |  October 25, 2010 FREE
Physical Activity and Risk of Breast Cancer Among Postmenopausal Women
A. Heather Eliassen, ScD; Susan E. Hankinson, RN, ScD; Bernard Rosner, PhD; et al.
Arch Intern Med. 2010;170(19):1758-1764. doi:10.1001/archinternmed.2010.363.
Editor's Correspondence |  October 25, 2010
Could Proton Pump Inhibitors Cause Cancer?
Paul J. Rosch, MD
Arch Intern Med. 2010;170(19):1775-1776. doi:10.1001/archinternmed.2010.375.
Invited Commentary |  October 11, 2010
The Vital Amines: Too Much of a Good Thing?:  Comment on “Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality”
Jeffrey A. Tice, MD
Arch Intern Med. 2010;170(18):1631-1633. doi:10.1001/archinternmed.2010.338.
Original Investigation |  October 11, 2010 FREE
Somatic Symptoms in Patients With Cancer Experiencing Pain or Depression:  Prevalence, Disability, and Health Care Use
Kurt Kroenke, MD; Xin Zhong, RN; Dale Theobald, MD, PhD; et al.
Arch Intern Med. 2010;170(18):1686-1694. doi:10.1001/archinternmed.2010.337.
Review Article |  October 11, 2010 FREE
Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality:  Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals
Robert Clarke, FRCP; Jim Halsey, BSc; Sarah Lewington, DPhil; et al.
Arch Intern Med. 2010;170(18):1622-1631. doi:10.1001/archinternmed.2010.348.
INCLUDES: , Supplemental Content
Research Letters |  September 27, 2010 FREE
Combined Influence of Health Behaviors on Total and Cause-Specific Mortality
Bamini Gopinath, PhD; Victoria M. Flood, PhD; George Burlutsky, MApplStat; et al.
Arch Intern Med. 2010;170(17):1605-1607. doi:10.1001/archinternmed.2010.303.
Special Article |  September 13, 2010
Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents
Charles L. Bennett, MD, PhD, MPP; Stephen Y. Lai, MD, PhD; Michael Henke, MD; et al.
Arch Intern Med. 2010;170(16):1490-1498. doi:10.1001/archinternmed.2010.309.
Invited Commentary |  August 09, 2010
An Appraisal of Non–AIDS-Defining Cancers:  Comment on “Spectrum of Cancer Risk Late After AIDS Onset in the United States”
Dirk P. Dittmer, PhD
Arch Intern Med. 2010;170(15):1345-1346. doi:10.1001/archinternmed.2010.250.
Research Letters |  August 09, 2010 FREE
Severity of Comorbidity and Non–Prostate Cancer Mortality in Men With Early-Stage Prostate Cancer
Timothy Daskivich, MD; Natalia Sadetsky, MD, PhD; Sherrie H. Kaplan, PhD, MPH; et al.
Arch Intern Med. 2010;170(15):1396-1397. doi:10.1001/archinternmed.2010.251.
Research Letters |  August 09, 2010 FREE
Invited Commentary—Prostate Cancer: Doing Less Might Be More:  Comment on "Severity of Comorbidity and Non–Prostate Cancer Mortality in Men With Early-Stage Prostate Cancer"
Richard J. Ablin, PhD; Oliver Sartor, MD; Charles L. Bennett, MD, PhD, MPP
Arch Intern Med. 2010;170(15):1397-1399. doi:10.1001/archinternmed.2010.290.
Original Investigation |  August 09, 2010 FREE
Waist Circumference and All-Cause Mortality in a Large US Cohort
Eric J. Jacobs, PhD; Christina C. Newton, MSPH; Yiting Wang, PhD; et al.
Arch Intern Med. 2010;170(15):1293-1301. doi:10.1001/archinternmed.2010.201.
INCLUDES: , Supplemental Content
Original Investigation |  August 09, 2010 FREE
Spectrum of Cancer Risk Late After AIDS Onset in the United States
Edgar P. Simard, PhD, MPH; Ruth M. Pfeiffer, PhD; Eric A. Engels, MD, MPH
Arch Intern Med. 2010;170(15):1337-1345. doi:10.1001/archinternmed.2010.253.
Original Investigation |  August 09, 2010 FREE
Impact of Biochemical Recurrence in Prostate Cancer Among US Veterans
Edward M. Uchio, MD; Mihaela Aslan, PhD; Carolyn K. Wells, MPH; et al.
Arch Intern Med. 2010;170(15):1390-1395. doi:10.1001/archinternmed.2010.262.
Invited Commentary |  July 26, 2010
The Cautionary Tale of PSA Testing:  Comment on “Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL”
Richard M. Hoffman, MD, MPH; Steven B. Zeliadt, PhD
Arch Intern Med. 2010;170(14):1262-1263. doi:10.1001/archinternmed.2010.222.
Original Investigation |  July 26, 2010 FREE
Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL
Yu-Hsuan Shao, PhD; Peter C. Albertsen, MD; Calpurnyia B. Roberts, PhD; et al.
Arch Intern Med. 2010;170(14):1256-1261. doi:10.1001/archinternmed.2010.221.
Research Letters |  July 26, 2010 FREE
Eyelash Preservation During Chemotherapy and Topical Prostaglandin Therapy
Sayoko E. Moroi, MD, PhD
Arch Intern Med. 2010;170(14):1269-1270. doi:10.1001/archinternmed.2010.247.
Invited Commentary |  July 12, 2010
Moving Toward Personalization of Colorectal Cancer Screening:  Comment on “Influence of Race and Sex on Prevalence and Recurrence of Colon Polyps”
Hemant K. Roy, MD; Laura K. Bianchi, MD
Arch Intern Med. 2010;170(13):1132-1134. doi:10.1001/archinternmed.2010.206.
Original Investigation |  July 12, 2010 FREE
Influence of Race and Sex on Prevalence and Recurrence of Colon Polyps
Eli Penn, MD; Donald Garrow, MD, MS; Joseph Romagnuolo, MD, FRCPC, MSc
Arch Intern Med. 2010;170(13):1127-1132. doi:10.1001/archinternmed.2010.152.
Comments, Opinions, and Brief Case Reports |  June 28, 2010
Prasugrel as a Potential Cancer Promoter: Review of the Unpublished Data
James S. Floyd, MD; Victor L. Serebruany, MD, PhD
Arch Intern Med. 2010;170(12):1078-1080. doi:10.1001/archinternmed.2010.154.
Editorial |  June 28, 2010
Prasugrel and Cancer:  An Uncertain Association or a Credible Risk That Meaningfully Alters the Benefit-Risk Balance
Sanjay Kaul, MD; George A. Diamond, MD
Arch Intern Med. 2010;170(12):1010-1012. doi:10.1001/archinternmed.2010.139.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis:  Analysis of 7872 Consecutive Eyes
Carol L. Shields, MD; Swathi Kaliki, MD; Michael Livesey, BS; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  May 16, 2013
An Oral Cavity Carcinoma Nomogram to Predict Benefit of Adjuvant Radiotherapy
Samuel J. Wang, MD, PhD; Snehal G. Patel, MD; Jatin P. Shah, MD; et al.
JAMA
Viewpoint  |  April 22, 2013
Cost Consequences of the 340B Drug Discount Program
Rena M. Conti, PhD; Peter B. Bach, MD, MAPP
JAMA
JAMA Patient Page  |  May 08, 2013
Lung Cancer Screening
Phillip M. Boiselle, MD; Cassio Lynm, MA; Edward H. Livingston, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems